Researchers and Clinicians
This trial assessed the safety and efficacy of the EryDex System to treat neurological symptoms associated with A-T.
Goals of this study are to develop non-invasive markers that will lessen the impact of swallowing dysfunction.
This study aimed to determine if inositol has therapeutic benefit for total lymphocyte count or ataxia.
Information on where to find commercially produced antibodies.
IntraBio, Inc. is studying the effects of N-Acetyl-L-Leucine on A-T.
This study seeks to develop sensitive, automated and objective means of measuring neurological disease severity.
- « Previous
- 1
- 2
- 3